Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men (2012)
- Authors:
- Lu, Beibei
- Viscidi, Raphael P.
- Wu, Yougui
- Lee, Ji-Hyun
- Nyitray, Alan G.
- Villa, Luisa L.
- Lazcano-Ponce, Eduardo - Instituto Nacional de Salud Pública (INSP-MX)
- Silva, Roberto J. Carvalho da
- Baggio, Maria Luiza
- Quiterio, Manuel - Instituto Nacional de Salud Pública (INSP-MX)
- Salmeron, Jorge
- Smith, Danelle C.
- Abrahamsen, Martha E.
- Papenfuss, Mary R.
- Stockwell, Heather G.
- Giuliano, Anna R.
- Autor USP: VILLA, LUISA LINA - FM
- Unidade: FM
- DOI: 10.1158/0008-5472.CAN-11-0751
- Subjects: VACINAS VIRAIS; IMUNIZAÇÃO; ONCOGENES; NEOPLASIAS DO COLO UTERINO; ANTICORPOS; BIOMARCADORES; HPV (IMUNOLOGIA)
- Language: Inglês
- Imprenta:
- Source:
- Título: Cancer Research
- ISSN: 0008-5472
- Volume/Número/Paginação/Ano: v. 72, n. 3, p. 676-685, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LU, Beibei et al. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men. Cancer Research, v. 72, n. 3, p. 676-685, 2012Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.CAN-11-0751. Acesso em: 14 fev. 2026. -
APA
Lu, B., Viscidi, R. P., Wu, Y., Lee, J. -H., Nyitray, A. G., Villa, L. L., et al. (2012). Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men. Cancer Research, 72( 3), 676-685. doi:10.1158/0008-5472.CAN-11-0751 -
NLM
Lu B, Viscidi RP, Wu Y, Lee J-H, Nyitray AG, Villa LL, Lazcano-Ponce E, Silva RJC da, Baggio ML, Quiterio M, Salmeron J, Smith DC, Abrahamsen ME, Papenfuss MR, Stockwell HG, Giuliano AR. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men [Internet]. Cancer Research. 2012 ; 72( 3): 676-685.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1158/0008-5472.CAN-11-0751 -
Vancouver
Lu B, Viscidi RP, Wu Y, Lee J-H, Nyitray AG, Villa LL, Lazcano-Ponce E, Silva RJC da, Baggio ML, Quiterio M, Salmeron J, Smith DC, Abrahamsen ME, Papenfuss MR, Stockwell HG, Giuliano AR. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men [Internet]. Cancer Research. 2012 ; 72( 3): 676-685.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1158/0008-5472.CAN-11-0751 - The Asian-American variant of human papillomavirus type 16 exhibits higher activation of MAPK and PI3K/AKT signaling pathways, transformation, migration and invasion of primary human keratinocytes
- HPV-6 Molecular Variants Association With the Development of Genital Warts in Men: The HIM Study
- Betapapillomavirus natural history and co-detection with alphapapillomavirus in cervical samples of adult women
- Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study
- Human papillomavirus (HPV) 16 E6 oncoprotein targets the Toll-like receptor pathway
- Human papillomavirus is not associated to non-small cell lung cancer: data from a prospective cross-sectional study
- Prevalence of high risk HPV DNA in esophagus is high in Brazil but not related to esophageal squamous cell carcinoma
- Human papillomavirus type 16 viral load measurement as a predictor of infection clearance
- Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas
- Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity
Informações sobre o DOI: 10.1158/0008-5472.CAN-11-0751 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
